Dispute over chess move ends with murder and cannibalism

Click to enlarge

An Italian man was arrested in Dublin on Sunday and charged with killing his Irish landlord and attempting to eat his heart after an argument about a game of chess.

Police said that 34-year-old Saverio Bellante admitted to killing Tom O’Gorman, 39.

O’Gormans body had been stabbed dozens of times and his chest cavity was opened up. Although the heart was still in his body, a lung was missing…

“The victim’s heart was intact but the post-mortem confirms that a lung was removed from the body and has not been located,” the source said. “The investigation is following a definite line of inquiry.”

At his arraignment on Monday, Bellante requested to represent himself and offered no plea. According to Det. Patrick Traynor, when Bellante was charged with murder, he replied: “I am guilty.”

The argument allegedly occurred over a move in a chess game that Bellante and O’Gorman had been playing for a year.

This blog and those involved with its production are all friendly to the discipline, skill and history of chess. At least one of us is damned good. It ain’t me.

We all understand that things like this can happen. They also happen between people watching telenovellas. We don’t approve of either circumstance allowed to descend into violence. 🙂

Arthritis meds may increase likelihood of dying from lung fungus?

The Food and Drug Administration ordered stronger warnings about the risk of potentially deadly fungal infections on four medications widely used to treat rheumatoid arthritis and other serious illnesses. The FDA has received 240 reports of patients taking such drugs as Cimzia, Enbrel, Humira, and Remicade, known as TNF-alpha blockers, who said the drug lowered the body’s defense to infections. Overall, 45 patients died. They developed histoplasmosis, a fungal infection which spreads throughout the body.

The drugs work by suppressing the immune system to keep it from attacking the body and they are approved to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, plaque psoriasis, ankylosing spondylitis and Crohn’s disease. But the treatment can leave patients vulnerable to other complications, or diseases.

“FDA has asked the manufacturers of these four drug products to highlight existing warnings of fungal infections,” Dr. Jeffrey Siegel, clinical team leader at the FDA…He added that the box warning must be upgraded to “strongly warn doctors to consider the occurrence of histoplasmosis and other fungal infections.”

The agency is also investigating a possible link between the four medications and cancer in young patients. The FDA had received 30 reports of cancers, mainly lymphomas, in patients who began taking the medications when they were 18 or younger. The agency said it has a six-month timeline for the review. “We intend to meet that timeline,” Siegel said.

Scary stuff. Once again, you have to question the thoroughness of FDA pre-release testing.